Insider · CIK 0001364475

Pauli Ronald

Reports to the SEC for 4 companies · SCHAUMBURG, IL

sec.gov

Transactions

Companies

Filings

CIK

0001364475

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−6,014 sh	$25.99	−$156K	33,600
2019-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.3K sh	—	—	0
2019-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.3K sh	—	—	39,614
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.1K sh	—	—	0
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.3K sh	—	—	15,320
2018-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+32.2K sh	—	—	32,161
2018-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14.1K sh	—	—	28,084
2018-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−3,790 sh	$13.87	−$52.6K	24,294
2017-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+31.2K sh	—	—	31,153
2017-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14K sh	—	—	17,793
2017-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−3,763 sh	$15.12	−$56.9K	14,030
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14K sh	—	—	0
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+14.1K sh	—	—	14,054
2016-05-06	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,418 sh	$13.41	−$19K	3,840
2016-05-06	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+5,258 sh	—	—	5,258
2016-05-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,258 sh	—	—	0
2016-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+23.1K sh	—	—	23,092
2016-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+14K sh	—	—	13,953
2015-05-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+8,548 sh	—	—	8,548
2015-05-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+5,258 sh	—	—	5,258
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,265 sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+5,265 sh	—	—	5,265
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,530
2013-05-31	Horizon Therapeutics Public Ltd CoNon-qualified stock optionsA Award	Director	AAward	+20K sh	—	—	20,000
2012-06-08	Horizon Therapeutics Public Ltd CoNon-qualified stock optionsA Award	Director	AAward	+5,265 sh	—	—	5,265
2012-02-22	Sagent Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+3,680 sh	—	—	3,680
2012-02-22	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Chief Financial Officer	AAward	+6,570 sh	—	—	6,570
2011-09-29	Horizon Therapeutics Public Ltd CoNon-qualified stock optionsA Award	Director	AAward	+10.5K sh	—	—	10,530
2006-08-28	NEOPHARM INCCommonA Award	Executive Vice President	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
May 64
Pauli Ronald0001209191-19-027813
SEC(opens sec.gov)
May 74
Pauli Ronald0001209191-18-028364
SEC(opens sec.gov)
May 44
Horizon Pharma plc0001209191-17-030118
SEC(opens sec.gov)
May 104
Horizon Pharma plc0001209191-16-118824
SEC(opens sec.gov)
May 54
Horizon Pharma plc0001209191-16-117860
SEC(opens sec.gov)
May 84
Horizon Pharma plc0001209191-15-040703
SEC(opens sec.gov)

Companies

Address

C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700

SCHAUMBURG, IL, 60195